Difficulty: Medium
Average Score: 94%
Practice
Guaifenesin promotes increased cough production by increasing and thinning mucous secretions. These actions allow patients to decrease chest congestion by coughing out secretions by which of the following mechanisms?
Correct answer
A
Rationale
The correct answer is A) Guaifenesin is an expectorant and has mucolytic properties.
Explain why the correct answer is right: Guaifenesin works as an expectorant by increasing the volume and reducing the viscosity of respiratory tract secretions. This helps to loosen and thin out mucus in the airways, making it easier for patients to cough out the secretions and alleviate chest congestion.
Explain why others are wrong:
B) Guaifenesin is not a bronchodilator with beta-adrenergic properties. It does not work by dilating the airways to improve airflow.
C) Guaifenesin is not an anti-inflammatory drug that suppresses airway mucus production. Its mechanism of action is not related to anti-inflammatory properties.
D) Guaifenesin is not a leukotriene modifier that reduces airway edema. It does not target leukotrienes or edema in the airways.
Educational context: Understanding the mechanism of action of guaifenesin is crucial in the management of respiratory conditions such as cough and chest congestion. By knowing how guaifenesin works as an expectorant and mucolytic agent, healthcare professionals can make informed decisions when recommending this medication to patients with respiratory issues.
Explain why the correct answer is right: Guaifenesin works as an expectorant by increasing the volume and reducing the viscosity of respiratory tract secretions. This helps to loosen and thin out mucus in the airways, making it easier for patients to cough out the secretions and alleviate chest congestion.
Explain why others are wrong:
B) Guaifenesin is not a bronchodilator with beta-adrenergic properties. It does not work by dilating the airways to improve airflow.
C) Guaifenesin is not an anti-inflammatory drug that suppresses airway mucus production. Its mechanism of action is not related to anti-inflammatory properties.
D) Guaifenesin is not a leukotriene modifier that reduces airway edema. It does not target leukotrienes or edema in the airways.
Educational context: Understanding the mechanism of action of guaifenesin is crucial in the management of respiratory conditions such as cough and chest congestion. By knowing how guaifenesin works as an expectorant and mucolytic agent, healthcare professionals can make informed decisions when recommending this medication to patients with respiratory issues.